CompaniesMGC Pharmaceuticals

MGC Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

542

By Phase

PHASE2: 3PHASE3: 1

By Status

COMPLETED: 2WITHDRAWN: 1UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
Today
NCT04802382
Hover over trial bars to see details

Recent Trials

NCT04406948Lead Sponsor
Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies
PHASE2Withdrawn
Started: May 30, 2024 · Completed: May 30, 2024
NCT05037162Lead Sponsor
Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
PHASE2Completed
240 participants
Started: Oct 11, 2022 · Completed: Mar 1, 2023
NCT04802382Lead Sponsor
Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
PHASE3Unknown
252 participants
Started: Jun 11, 2021 · Completed: Apr 30, 2023
NCT04382040Lead Sponsor
A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19
PHASE2Completed
50 participants
Started: May 8, 2020 · Completed: Dec 21, 2020